Filing Details
- Accession Number:
- 0001209191-20-002285
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-01-07 16:35:41
- Reporting Period:
- 2020-01-03
- Accepted Time:
- 2020-01-07 16:35:41
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1419600 | Flexion Therapeutics Inc | FLXN | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1617236 | S. Mark Levine | C/O Flexion Therapeutics, Inc. 10 Mall Road, Suite 301 Burlington MA 01803 | General Counsel | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2020-01-03 | 3,724 | $0.00 | 43,487 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Sale of shares of common stock to cover tax withholding obligations associated with the vesting of restricted stock unit award granted to the Reporting Person on February 1, 2018 and March 1, 2019.
- The shares were sold at a range of prices between $19.74 and $19.82. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
- Includes 938 shares of Common Stock that were acquired by the Reporting Person on December 20, 2019 at $9.89 per share pursuant to the Issuer's Employee Stock Purchase Plan.
Billionaire Hedge Funds
